Completed NA INTERVENTIONAL 2-arm NCT01967472

Adherence to Antimalarial Drugs in Sierra Leone

Adherence to Artemisinin-Based Combination Therapy (ACT) for the Treatment of Malaria in Sierra Leone

Sponsor: London School of Hygiene and Tropical Medicine

Conditions Malaria

Interventions Artemether-lumefantrine combination (AL) dispersable amodiaquine-artesunate (AQAS) fixed-dose

Updated 6 times since 2017 Last updated: Jan 10, 2018 Started: Sep 16, 2013 Primary completion: Dec 31, 2013 Completion: Jan 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Malaria and is currently completed. London School of Hygiene and Tropical Medicine leads this study, which shows 6 recorded versions since 2013 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2018 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2018 [monthly]

Completed NA

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

London School of Hygiene and Tropical Medicine
National Malaria Control Program, Ministry of Health and Sanitation
Pharmacy Board of Sierra Leone, Ministry of Health and Sanitation

Data source: London School of Hygiene and Tropical Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Freetown, Sierra Leone